Source: American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. Unidade: FMRP
Subjects: CORAÇÃO (FISIOPATOLOGIA;EFEITOS DE DROGAS), INIBIDORES DE ENZIMAS (FARMACOLOGIA), SISTEMA NERVOSO PARASSIMPÁTICO, VENTRÍCULO CARDÍACO
ABNT
LATARO, Renata Maria et al. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, v. 305, n. 8, p. R908-R916, 2013Tradução . . Disponível em: https://doi.org/10.1152/ajpregu.00102.2013. Acesso em: 28 set. 2024.APA
Lataro, R. M., Silva, C. A. A. da, Fazan Júnior, R., Rossi, M. A., Prado, C. M., Godinho, R. O., & Salgado, H. C. (2013). Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 305( 8), R908-R916. doi:10.1152/ajpregu.00102.2013NLM
Lataro RM, Silva CAA da, Fazan Júnior R, Rossi MA, Prado CM, Godinho RO, Salgado HC. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure [Internet]. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. 2013 ; 305( 8): R908-R916.[citado 2024 set. 28 ] Available from: https://doi.org/10.1152/ajpregu.00102.2013Vancouver
Lataro RM, Silva CAA da, Fazan Júnior R, Rossi MA, Prado CM, Godinho RO, Salgado HC. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure [Internet]. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. 2013 ; 305( 8): R908-R916.[citado 2024 set. 28 ] Available from: https://doi.org/10.1152/ajpregu.00102.2013